# High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II

> **NCT07059728** · NA · RECRUITING · sponsor: **Hospital Clinic of Barcelona** · enrollment: 452 (estimated)

## Conditions studied

- Aortic Stenosis Treated With TAVI
- Sedation; Aged; Hemodynamics

## Interventions

- **DEVICE:** Oxygen therapy during sedation provided via high nasal cannulae (60L/min at 60% FiO2)
- **DEVICE:** Oxygen therapy during sedation delivered via nasal cannulae at 5L/min

## Key facts

- **NCT ID:** NCT07059728
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2026-07
- **Final completion:** 2027-07
- **Target enrollment:** 452 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07059728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07059728, "High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07059728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*